ASTRAZENECA PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 2.5%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 2.5%
Wed, 20 May

ASTRAZENECA PHARMA has announced its results for the quarter ended March 2020. Here is a detailed performance review of the same:

ASTRAZENECA PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-19*
3
Dec-19*
3
Mar-20*
QoQ ChangeYoY Change
Net SalesRs m1,9032,2391,949-12.9%2.4%
Other incomeRs m603534-2.5%-43.8%
TurnoverRs m1,9632,2731,983-12.8%1.0%
ExpensesRs m1,8391,8711,801-3.7%-2.1%
Gross profitRs m64368148-59.7%132.5%
DepreciationRs m394845-4.7%16.3%
InterestRs m0335.5%0.0%
Profit before taxRs m85352134-62.0%57.6%
TaxRs m-148538-55.5%
Profit after taxRs m9826796-64.1%-2.5%
Gross profit margin%3.316.47.6
Effective tax rate%-15.924.128.3
Net profit margin%5.011.74.8
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 2.4% on a year-on-year (YoY) basis. The expenses were down by 2.1% YoY during the same period.
  • The company's operating profit increased by 132.5% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 7.6% in 4QFY20 as against 3.3% in 4QFY19.
  • Depreciation charges increased by 16.3% and finance costs increased by 0.0% YoY, respectively.
  • Other income declined by 43.8% YoY during the quarter.
  • Net profit for the quarter declined by 2.5% YoY. Net profit margins during the quarter declined from 5.0% in 4QFY19 to 4.8% in 4QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 12.9% on a quarter-on-quarter (QoQ) basis. The expenses were down by 3.7% QoQ during the same period.
  • The company's operating profit declined by 59.7% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 7.6% in 4QFY20 as against 16.4% in 3QFY19.
  • Net profit for the quarter declined by 64.1% QoQ, while net profit margins declined from 11.7% in 3QFY19 to 4.8% in 4QFY20.

To see how ASTRAZENECA PHARMA has performed over the last eight quarters,please visit here.

The Instant Income Summit: Free Registration

ASTRAZENECA PHARMA Share Price Performance

Over the last one year,ASTRAZENECA PHARMA share price has moved up from Rs 2,291.9 to Rs 2,728.1, registering a Gain of Rs 436.2 or around 19.0%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 15,053.9 (up 1.1%). Over the last one year it has moved up from 13,341.1 to 15,053.9, a gain of 1,713 points (up 12.8%).

Overall, the S&P BSE SENSEX is down 22.8% over the year.

Current Valuations

At the current price of Rs 2,728.1, the price to earnings (P/E) ratio of ASTRAZENECA PHARMA stands at 94.4 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 27.6 times.

Equitymaster requests your view! Post a comment on "ASTRAZENECA PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 2.5%". Click here!

  

Related Views on News

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 236.5% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 215 m (up 236.5% YoY). Sales on the other hand came in at Rs 2 bn (up 26.7% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 204.9% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 98 m (up 204.9% YoY). Sales on the other hand came in at Rs 2 bn (up 26.3% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Mar 29, 2019 | Updated on Mar 29, 2019

Here's an analysis of the annual report of ASTRAZENECA PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ASTRAZENECA PHARMA. Also includes updates on the valuation of ASTRAZENECA PHARMA.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ASTRAZENECA PHARMA SHARE PRICE


Jul 7, 2020 (Close)

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA - ALEMBIC LTD COMPARISON

COMPARE ASTRAZENECA PHARMA WITH

MARKET STATS